Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Philip J. O'Dell"'
Autor:
Alexandra M. Adams, Nicholas A. Anas, Abhishek K. Sen, Jordan D. Hinegardner-Hendricks, Philip J. O’Dell, William J. Gibbons, Jr., Jessica E. Flower, Matthew S. McMurray, J. Andrew Jones
Publikováno v:
Metabolic Engineering Communications, Vol 14, Iss , Pp e00196- (2022)
Interest in the potential therapeutic efficacy of psilocybin and other psychedelic compounds has escalated significantly in recent years. To date, little is known regarding the biological activity of the psilocybin pathway intermediate, norbaeocystin
Externí odkaz:
https://doaj.org/article/8618c3a378634ed5a5a5fbbbc8f123f5
Autor:
J. Andrew Jones, Madeline G. McKinney, Brooke A. Bollinger, Philip J. O’Dell, William J. Gibbons
Publikováno v:
DOAJ-Articles
PubMed Central
Datacite
UnpayWall
ORCID
Microsoft Academic Graph
Bioengineered, Vol 12, Iss 1, Pp 8863-8871 (2021)
article-version (VoR) Version of Record
Bioengineered
PubMed Central
Datacite
UnpayWall
ORCID
Microsoft Academic Graph
Bioengineered, Vol 12, Iss 1, Pp 8863-8871 (2021)
article-version (VoR) Version of Record
Bioengineered
Psilocybin, a drug most commonly recognized as a recreational psychedelic, is quickly gaining attention as a promising therapy for an expanding range of neurological conditions, including depression, anxiety, and addiction. This growing interest has